BMN 349 (Crovozalpon, BMN349) | Z α1-antitrypsin polymerisation inhibitor

Chemical Structure : BMN 349

加入收藏

BMN 349 (Crovozalpon, BMN349, BMN-349)

货号: PC-25037Not For Human Use, Lab Use Only.

BMN 349 (Crovozalpon, BMN349) is a specific small molecule inhibitor of Z mutant alpha-1 antitrypsin (Z-AAT) polymerization that preferentially binds Z-AAT and blocks polymerization.

规格	价格	库存	数量
50 mg		Get quote
100 mg		Get quote
250 mg		Get quote

获取报价单

* 请选择数量再加入购物车

or Bulk Inquiry

大包装，大折扣！

E-mail: sales@probechem.com

Tech Support: tech@probechem.com

生物&药学活性

BMN 349 (Crovozalpon, BMN349) is a specific small molecule inhibitor of Z mutant alpha-1 antitrypsin (Z-AAT) polymerization that preferentially binds Z-AAT and blocks polymerization.

BMN 349 binds human plasma Z-AAT ~150 times faster than human plasma M-AAT, with calculated kapp of 2.49 ×104 M−1 s−1 and 1.59 ×102 M−1 s−1 for Z- and M-AAT, respectively.

BMN 349 reduces polymerization and increases secretion of Z-AAT in Tet-inducible CHO cell model expressing Z-AAT.

BMN 349 induces dose-dependent increase in total Z-AAT (EC50=0.91 μM) and a decrease in polymeric Z-AAT (EC50=1.57 μM) at the 48-hour time point in CHO-K1-Tet-Z-AAT cells.

BMN 349 binds to a cryptic pocket in alpha-1 antitrypsin (AAT).

( 20 mg/kg/day and 60 mg/kg/day, oral gavage) treatment results dose-dependent increases in total plasma Z-AAT and a concurrent decrease in circulating and liver Z-AAT polymers.

BMN 349 (Crovozalpon) decrease in circulating and liver Z-AAT polymers in mouse models of human AAT deficiency (AATD) associated liver disease.

BMN 349 rapidly and potently inhibits hepatic Z-AAT polymerization and accumulation, thereby enhancing Z-AAT secretion and improving overall liver health in PiZ mice.

物理化学性质&存储条件

分子量	408.83
分子式	C20H19ClF2N2O3
外观性状	Solid
CAS No.
储存条件	固体粉末 -20°C 12 个月; 4°C 6 个月	配置液 -80°C 6 个月; -20°C 6 个月
Shipping
Solubility	10 mM in DMSO
Chemical Name/SMILES	N-((1S,2R)-1-(2-chloro-3-fluorophenyl)-1-hydroxypentan-2-yl)-7-fluoro-2-oxoindoline-4-carboxamide

参考文献

1. Patent WO2025049912 A1.; 2. Handyside B, et al. Hepatology. 2026 May 1. doi: 10.1097/HEP.0000000000001778.

BMN 349 (Crovozalpon, BMN349, BMN-349)

生物&药学活性

物理化学性质&存储条件

参考文献

Bulk Inquiry

* Indicates a Required FieldYour information is safe with us.

询单

BMN 349 (Crovozalpon, BMN349, BMN-349)

生物&药学活性

物理化学性质&存储条件

参考文献

Bulk Inquiry

* Indicates a Required FieldYour information is safe with us.

询单

Get Quotation Now

* Indicates a Required FieldYour information is safe with us.